A 'small sale for MannKind' as it offloads Californian HQ and production site
MannKind Corporation has agreed to sell its headquarters and manufacturing site in Valencia, California to Rexford Industrial Realty for $17.3m.
Archives for January 25, 2017
Enteris to work on Sanofi oral type 2 diabetes candidate & metabolic peptide for Nordic Bioscience
Sanofi and Nordic Bioscience deals ‘validate’ oral delivery tech, Enteris
Enteris Biopharma has secured two deals in as many days to use its excipient-based platform to enhance delivery of preclinical peptide candidates.
scope 2017
Continuum teams with Lyft for clinical trials transportation
Contiunuum Clinical has asked rideshare firm Lyft to help transport trial subjects to clinical sites in a bid to boost retention.
Diurnal outsources launch of Adrenal drug to Dublin divisions of UDG
Diurnal has contracted the Ashfield and Sharp divisions of UDG Healthcare to help commercialize the its drug for Addison's disease, Infacort.
Wuxi Biologics files IPO prospectus aiming to be gateway to China
Wuxi Biologics has confirmed its intention to go public in an IPO application that reveals the contracter has seen revenue double and profits increase three-fold since 2014.
scope 2017
CROS NT launches new FSP model focused on 'sustainable quality'
The Functional Service Provision (FSP) model unveiled at SCOPE Summit this week in Miami addresses staff turnover, flexible pricing, and monitoring.
FDA hits UK state-owned CDMO with warning over leukemia drug production
Porton Biopharma says it is undergoing a manufacturing review to address US FDA concerns about the production of Jazz Pharmaceuticals’s orphan drug Erwinaze.